Precision medicine
In part one of our new Emerging Technologies series, Jayme Strauss, chief clinical and commercial officer at Precision Neuroscience, discusses the Layer 7 cortical interface, a minimally invasive brain-computer interface.
Gene and cell therapies can "reprogram" patients' own cells to stop the progression of certain cancers and genetic conditions in some situations, with remission rates of up to 92%, says Boro Dropulić, executive director of Caring Cross.
Nearly a decade since launching his Cancer Moonshot, the oncology research and precision medicine innovations of that project, along with other NIH-funded health data initiatives, have enabled advancements in personalized treatment and management.
They're used to forecast the longitudinal behavior of trial participants – and by predicting individuals' likely response to a drug, can improve data quality and shorten trial timelines, says Unlearn CEO Steven Herne.
Amprion has partnered with Mayo Clinic Laboratories to expand access to its test, which detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy. Russ Lebovitz, the company's CEO, explains.
Mariam AlEissa, adjunct assistant professor at Alfaisal University in Saudi Arabia, explains how genomics data can identify causes of, and help develop treatments for, non-communicable diseases.
SPONSORED
|
05:45 pm |
March 27, 2025
|
05:45 pm |
March 27, 2025
Clinical pathways provide evidence-based treatment guidance that supports standardization of care. In a roundtable and webinar, sponsored by Elsevier's ClinicalPath, oncology leaders and pathway experts discussed the benefits and appropriate use of clinical pathways in oncology. This report presents valuable insights from those discussions.
It has also revealed ongoing work applying AI to track medical resource utilisation in real time.
Also, DrFirst earns HITRUST for electronic prior authorization, e-prescribing, patient engagement and other healthcare tools.
Genomics CEO Sir Peter Donnelly believes genome testing will become routine within 10 years, leading to lives saved.